vs
Phoenix Education Partners, Inc.（PXED）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
Phoenix Education Partners, Inc.的季度营收约是REPLIGEN CORP的1.1倍（$222.5M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs 4.8%，领先1.9%），Phoenix Education Partners, Inc.自由现金流更多（$43.5M vs $17.6M）
凤凰城大学是总部位于美国亚利桑那州凤凰城的私立营利性大学，由凤凰城教育合伙公司持有，1976年成立，可颁发证书及副学士、学士、硕士、博士多个层级的学位。该校获高等教育委员会官方认证，不少本科项目实行开放入学政策。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
PXED vs RGEN — 直观对比
营收规模更大
PXED
是对方的1.1倍
$197.9M
净利率更高
RGEN
高出1.9%
4.8%
自由现金流更多
PXED
多$26.0M
$17.6M
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $222.5M | $197.9M |
| 净利润 | $10.8M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 6.3% | 9.0% |
| 净利率 | 4.8% | 6.7% |
| 营收同比 | — | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益（稀释后） | $0.28 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PXEDRGEN
| Q1 26 | $222.5M | — | ||
| Q4 25 | $262.0M | $197.9M | ||
| Q3 25 | — | $188.8M | ||
| Q2 25 | — | $182.4M | ||
| Q1 25 | — | $169.2M | ||
| Q4 24 | — | $174.1M | ||
| Q3 24 | — | $154.9M | ||
| Q2 24 | — | $154.1M |
净利润PXEDRGEN
| Q1 26 | $10.8M | — | ||
| Q4 25 | $15.5M | $13.3M | ||
| Q3 25 | — | $14.9M | ||
| Q2 25 | — | $14.9M | ||
| Q1 25 | — | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | — | $-654.0K | ||
| Q2 24 | — | $3.3M |
毛利率PXEDRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率PXEDRGEN
| Q1 26 | 6.3% | — | ||
| Q4 25 | 9.8% | 9.0% | ||
| Q3 25 | — | 8.9% | ||
| Q2 25 | — | 7.6% | ||
| Q1 25 | — | 3.9% | ||
| Q4 24 | — | -17.7% | ||
| Q3 24 | — | -5.1% | ||
| Q2 24 | — | 1.0% |
净利率PXEDRGEN
| Q1 26 | 4.8% | — | ||
| Q4 25 | 5.9% | 6.7% | ||
| Q3 25 | — | 7.9% | ||
| Q2 25 | — | 8.2% | ||
| Q1 25 | — | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | — | -0.4% | ||
| Q2 24 | — | 2.2% |
每股收益（稀释后）PXEDRGEN
| Q1 26 | $0.28 | — | ||
| Q4 25 | $0.40 | $0.24 | ||
| Q3 25 | — | $0.26 | ||
| Q2 25 | — | $0.26 | ||
| Q1 25 | — | $0.10 | ||
| Q4 24 | — | $-0.55 | ||
| Q3 24 | — | $-0.01 | ||
| Q2 24 | — | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $201.4M | $767.6M |
| 总债务越低越好 | $58.8M | $542.2M |
| 股东权益账面价值 | $291.1M | $2.1B |
| 总资产 | $546.4M | $2.9B |
| 负债/权益比越低杠杆越低 | 0.20× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资PXEDRGEN
| Q1 26 | $201.4M | — | ||
| Q4 25 | $163.5M | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | — | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $809.1M |
总债务PXEDRGEN
| Q1 26 | $58.8M | — | ||
| Q4 25 | $61.6M | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益PXEDRGEN
| Q1 26 | $291.1M | — | ||
| Q4 25 | $280.4M | $2.1B | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | — | $2.1B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | — | $2.0B |
总资产PXEDRGEN
| Q1 26 | $546.4M | — | ||
| Q4 25 | $549.6M | $2.9B | ||
| Q3 25 | — | $2.9B | ||
| Q2 25 | — | $2.9B | ||
| Q1 25 | — | $2.9B | ||
| Q4 24 | — | $2.8B | ||
| Q3 24 | — | $2.8B | ||
| Q2 24 | — | $2.9B |
负债/权益比PXEDRGEN
| Q1 26 | 0.20× | — | ||
| Q4 25 | 0.22× | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $48.9M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $43.5M | $17.6M |
| 自由现金流率自由现金流/营收 | 19.6% | 8.9% |
| 资本支出强度资本支出/营收 | 2.4% | 4.1% |
| 现金转化率经营现金流/净利润 | 4.53× | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流PXEDRGEN
| Q1 26 | $48.9M | — | ||
| Q4 25 | $31.1M | $25.7M | ||
| Q3 25 | — | $48.1M | ||
| Q2 25 | — | $28.6M | ||
| Q1 25 | — | $15.0M | ||
| Q4 24 | — | $39.2M | ||
| Q3 24 | — | $49.3M | ||
| Q2 24 | — | $42.2M |
自由现金流PXEDRGEN
| Q1 26 | $43.5M | — | ||
| Q4 25 | $26.4M | $17.6M | ||
| Q3 25 | — | $43.4M | ||
| Q2 25 | — | $21.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | — | $42.3M | ||
| Q2 24 | — | $37.4M |
自由现金流率PXEDRGEN
| Q1 26 | 19.6% | — | ||
| Q4 25 | 10.1% | 8.9% | ||
| Q3 25 | — | 23.0% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | — | 27.3% | ||
| Q2 24 | — | 24.3% |
资本支出强度PXEDRGEN
| Q1 26 | 2.4% | — | ||
| Q4 25 | 1.8% | 4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 3.1% |
现金转化率PXEDRGEN
| Q1 26 | 4.53× | — | ||
| Q4 25 | 2.01× | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
